Polyphagia
| Polyphagia | |
|---|---|
| Classification and external resources | |
| ICD-10 | R63.2 |
| ICD-9-CM | 783.6 |
| DiseasesDB | 29453 |
| MeSH | D006963 |
Polyphagia or hyperphagia is excessive hunger or increased appetite.[1]
In medicine
In medicine, polyphagia (sometimes known as hyperphagia) is a medical sign meaning excessive hunger and abnormally large intake of solids by mouth. It can be caused by disorders such as diabetes, Kleine–Levin syndrome (a malfunction in the hypothalamus), and the genetic disorders Prader–Willi syndrome and Bardet–Biedl syndrome.[2]
Causes
Causes of increased appetite include:[3]
- Anxiety
- Depression
- Certain drugs
- Diabetes mellitus
- Hyperthyroidism
- Hypoglycemia
- Premenstrual syndrome
- Prader-Willi syndrome
- Bulimia
- Graves' disease
- Kleine–Levin syndrome
Diabetic ketoacidosis
Polyphagia usually occurs early in the course of diabetic ketoacidosis.[4] However, once insulin deficiency becomes more severe and ketoacidosis develops, appetite is suppressed.[5]
Etymology and pronunciation
The word polyphagia (/ˌpɒliˈfeɪdʒiə/) uses combining forms of poly- + -phagia, from the Greek words πολύς (polys), "very much" or "many", and φαγῶ (phago), "eating" or "devouring".
See also
References
- ↑ Berthoud HR, Lenard NR, Shin AC (2011). "Food reward, hyperphagia, and obesity.". Am J Physiol Regul Integr Comp Physiol. 300 (6): R1266–77. doi:10.1152/ajpregu.00028.2011. PMC 3119156
. PMID 21411768. - ↑ OMIM::Prader-WilliOMIM::Bardet-Biedl
- ↑ Updated by: Linda J. Vorvick, MD, Medical Director and Director of Didactic Curriculum, MEDEX Northwest Division of Physician Assistant Studies, Department of Family Medicine, UW Medicine, School of Medicine, University of Washington, Seattle, WA. Also reviewed David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. "Appetite - increased". nih.gov.
- ↑ Elliott RE, Jane JA, Wisoff JH (2011). "Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches.". Neurosurgery. 69 (3): 630–43; discussion 643. doi:10.1227/NEU.0b013e31821a872d. PMID 21499159.
- ↑ Masuzaki H, Tanaka T, Ebihara K, Hosoda K, Nakao K (2009). "Hypothalamic melanocortin signaling and leptin resistance--perspective of therapeutic application for obesity-diabetes syndrome.". Peptides. 30 (7): 1383–6. doi:10.1016/j.peptides.2009.04.008. PMID 19394382.